BRAINSTORM CELL THERAPEUTICS

CUSIP: 10501E201 Class: COM NEW

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 40,956 Value ($000) $84 Avg Close — Range —
Q1 2023
Shares 13,168 Value ($000) $43 Avg Close — Range —
Q4 2022
Shares 16,464 Value ($000) $27 Avg Close — Range —
Q3 2022
Shares 31,007 Value ($000) $137 Avg Close — Range —
Q2 2022
Shares 25,685 Value ($000) $70 Avg Close — Range —
Q1 2022
Shares 24,119 Value ($000) $81 Avg Close — Range —
Q3 2021
Shares 16,480 Value ($000) $54 Avg Close — Range —
Q2 2021
Shares 51,167 Value ($000) $195 Avg Close — Range —
Q1 2021
Shares 39,554 Value ($000) $151 Avg Close — Range —
Q4 2019
Shares 12,240 Value ($000) $52 Avg Close — Range —
Q2 2019
Shares 16,814 Value ($000) $66 Avg Close — Range —
Q1 2019
Shares 13,911 Value ($000) $60 Avg Close — Range —
Q4 2018
Shares 10,867 Value ($000) $39 Avg Close — Range —
Q4 2017
Shares 15,034 Value ($000) $59 Avg Close — Range —
Q3 2017
Shares 14,798 Value ($000) $61 Avg Close — Range —
Q1 2017
Shares 17,372 Value ($000) $74 Avg Close — Range —
Q1 2016
Shares 11,948 Value ($000) $32 Avg Close — Range —